Valuation: Byotrol plc

Market Cap 194K 261K 227K 213K 364K 24.93M 370K 2.5M 974K 12.5M 980K 960K 41.67M P/E 2023
-2.12x
P/E 2024 -0.06x
Enterprise Value 845K 1.14M 988K 927K 1.59M 109M 1.61M 10.89M 4.25M 54.49M 4.27M 4.18M 182M EV / Sales 2023
0.84x
EV / Sales 2024 0.21x
Free-Float
24.18%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 50 30/06/2024
Director TitleAgeSince
Chairman 75 21/04/2024
Director/Board Member 50 12/12/2021
Change 5-day change 1-year change 3-year change Capi.($)
-20.00%-20.00% - - 247K
+0.12%-1.73%-6.98%-8.13% 335B
+1.27%-3.05%-8.37%+0.78% 133B
+0.66%-0.38%+9.37%+20.85% 73.59B
+1.41%+0.32%-15.77%-16.38% 50.82B
+1.16%-2.39%-12.33%-19.06% 36.46B
-0.41%+0.41%-4.78%-47.91% 31.72B
-3.58%+11.57%+5.56%+24.18% 20.96B
-0.33%-4.40%-20.37%-35.11% 19.84B
+0.76%-1.87%+13.78%+7.31% 19.55B
Average -1.89%-0.21%-4.43%-8.16% 80.09B
Weighted average by Cap. +0.40%-1.71%-5.80%-5.80%

Financials

2023 2024
Net sales 4.59M 6.19M 5.37M 5.04M 8.63M 591M 8.77M 59.19M 23.08M 296M 23.23M 22.75M 988M 3.97M 5.35M 4.64M 4.36M 7.46M 511M 7.58M 51.17M 19.95M 256M 20.08M 19.66M 854M
Net income -1.69M -2.28M -1.98M -1.86M -3.18M -218M -3.23M -21.81M -8.5M -109M -8.56M -8.38M -364M -3.06M -4.13M -3.58M -3.36M -5.76M -394M -5.85M -39.5M -15.4M -198M -15.5M -15.18M -659M
Net Debt 287K 387K 336K 315K 539K 36.93M 548K 3.7M 1.44M 18.51M 1.45M 1.42M 61.73M 651K 878K 761K 715K 1.22M 83.77M 1.24M 8.39M 3.27M 41.99M 3.29M 3.22M 140M
Logo Byotrol plc
Byotrol Plc is a United Kingdom-based specialist infection prevention and control company. The Company operates globally in the animal and human healthcare, industrial, institutional and consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, molds, mycobacteria and algae. Its products can be used stand-alone or as ingredients within existing products, especially in personal hygiene, domestic and industrial disinfection, odor control, food production and food management. The Company sells products based on its anti-microbial technology to professional and consumer end users and retailers (product sales). In the professional sector, it serves human health, animal health and facilities management. In the consumer sector, it serves household, skin care and pet care. It serves customers in the United Kingdom; Europe, Middle East, and Africa (EMEA) and North America and Asia.
Employees
35